Clinical Trials List
Protocol NumberTED15297
Not yet recruiting
2020-11-25 - 2024-12-31
Phase I
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Muh-Hwa Yang Division of Hematology & Oncology
- 陳盛裕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
13 participants
-
Global
231 participants
